Skip to main
CVRX
CVRX logo

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 0%
Sell 17%
Strong Sell 0%

Bulls say

CVRx Inc has demonstrated strong expansion in its operational footprint, achieving an increase to 240 active implanting centers, reflecting a sequential growth of 13 centers. The company's total operating expenses rose approximately 8% year-over-year to $25.8 million, primarily due to a 11% increase in selling, general, and administrative expenses, which reached $23.4 million. This growth in implanting centers and the reinvestment in operational capabilities signify a commitment to expanding market reach and support for its proprietary Barostim technology, potentially positioning the company for sustained revenue growth in the cardiovascular medical device sector.

Bears say

CVRx Inc has revised its fiscal year 2025 revenue guidance to a range of $55.0 to $57.0 million, reflecting a modest growth projection of approximately 7-11% year-over-year, which is a reduction from the previous guidance range. Furthermore, the company has also lowered its revenue estimate for 2026 to $67.6 million from $74.1 million, indicating expectations of a moderated growth ramp in the U.S. market. Despite maintaining a gross margin of approximately 84% in the second quarter of 2025, these downward adjustments in revenue projections signal potential challenges in achieving growth targets, contributing to a negative outlook on the stock.

CVRx (CVRX) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 6 analysts, CVRx (CVRX) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.